USPTO Director Issues Second Sua Sponte Precedential Decision Addressing Abuse of Process

February 3, 2023

Reading Time : 3 min

In the wake of her October 4, 2022 Precedential OpenSky decision, the United States Patent and Trademark Office Director Katherine Vidal issued another precedential decision further clarifying the actions that should be considered when addressing allegations of abuse of process or conduct that otherwise thwarts the goals of the Office.

In district court litigation between Intel Corporation and VLSI Technology, LLC, a jury returned a verdict of $1.5 billion in early 2021 for infringement of the challenged patent in this proceeding. Shortly after the jury verdict, two entities—OpenSky Industries, LLC and Patent Quality Assurance—were formed. OpenSky filed two inter partes review (IPR) petitions challenging two different patents. OpenSky’s IPR petitions extensively copied Intel’s previous IPR petitions—which were denied due in part to the then co-pending litigation—and expert reports. Subsequently, PQA filed an IPR petition against one of those patents, which also largely copied Intel’s IPR petition and expert report. In its petition, PQA argued against discretionary denial because it had “exclusively” engaged Intel’s experts to challenge the patent-at-issue. Based partly on this representation, the Board denied OpenSky’s IPR petition challenging that patent, and instituted PQA’s IPR petition. Upon institution, Intel filed a motion for joinder with PQA’s proceeding, which the Board granted. The Director then ordered sua sponte review of the Board’s institution decision.

The Director took up this proceeding to address abuse of process issues, similar to those she addressed in OpenSky. But the Director highlighted some key differences. For example, in its petition, PQA represented that it had “exclusively engaged” both experts that Intel had engaged in its IPR petition. Based on this representation, the Board denied institution of OpenSky’s petition, since this arrangement meant that OpenSky could not present either expert for cross-examination in that proceeding. PQA later qualified this statement, indicating the exclusive agreement with the experts could be waived upon request. The Director noted that there was no evidence explaining why the retained experts were prohibited from working with other parties. From this, the Director inferred that PQA’s misrepresentation was in order to benefit monetarily from its petition by ensuring that OpenSky’s petition was denied and PQA’s petition was instituted.

The Director reiterated that when a petitioner has not been sued by the patent owner and is a non-practicing entity, there may be legitimate questions regarding whether the petitioner filed the petition for an improper purpose. A concern in these situations is that petitioners may file IPR petitions in order to obtain a cash settlement. This concern is amplified by the $1.5 billion jury verdict in favor of the patent owner. PQA was given the opportunity to present evidence that it had another purpose for filing its IPR petition, but it failed to do so. The Director found that the sole reason PQA filed its IPR petition was for the improper purpose of extracting money from VLSI. As a result, the Director dismissed PQA from the proceeding and made Intel the lead petitioner. Unlike in the OpenSky IPR—where the Director remanded for a determination of whether the petition met the compelling merits standard set forth in the June 21, 2022 Director’s memorandum—here, the Director herself found the compelling merits standard satisfied and allowed the IPR to proceed to a final written decision.

Practice Tip: The Director has made clear that the Patent Office will not allow parties to use the IPR process for an improper purpose, such as to extort a cash settlement. Where a party abuses the IPR process, the Patent Office may impose sanctions, including removal of that party from the proceeding. If a petitioner has not, or cannot, be sued by the patent owner, the petitioner may wish to include in its petition a legitimate explanation as to why it filed the petition. A patent owner challenging whether the IPR was filed for a proper purpose should also consider articulating why the petition also fails to meet the compelling merits standard.

Patent Quality Assurance, LLC, v. VLSI Technology LLC, IPR2021-01229, Paper 102 (Dec. 22, 2022) (precedential).

Share This Insight

Previous Entries

IP Newsflash

July 1, 2025

In an appeal from an inter partes review, the Federal Circuit recently clarified that the enablement inquiry applied to prior art references in the context of an anticipation defense differs from the enablement inquiry applied when evaluating the claims of a patent.

...

Read More

IP Newsflash

June 26, 2025

The Northern District of Ohio denied a motion to compel the plaintiff to produce test results referenced in its initial disclosures and complaint. The court found that because the “test results are not facts but rather are opinions,” the information was protected as work product. Furthermore, because that testing would not be used as evidence in the litigation, the defendant was not prejudiced.

...

Read More

IP Newsflash

June 6, 2025

In a precedential opinion, the Federal Circuit definitively held that the Patent Trial and Appeal Board has jurisdiction over IPRs that concern expired patents.

...

Read More

IP Newsflash

June 6, 2025

In a patent infringement litigation in the U.S. District Court for the Eastern District of Texas, Judge Rodney Gilstrap denied a joint motion to stay the litigation pending resolution of inter partes review when it was uncertain that all defendants would be bound by the statutory estoppel provision of 35 U.S.C. § 315(e).

...

Read More

IP Newsflash

May 30, 2025

A district court recently dismissed a patent infringement complaint for improper venue under 28 U.S.C. § 1400(b), finding that the storage and distribution of products from an Amazon warehouse was not sufficient to establish that warehouse as a regular and established place of business in the district.

...

Read More

IP Newsflash

May 27, 2025

The Federal Circuit affirmed a District of Delaware finding of non-infringement in an ANDA litigation due to the patentee’s clear and unmistakable disavowal of claim scope during prosecution. Specifically, the court held that statements made during prosecution of a parent application before the asserted claims were allowed amounted to a prosecution disclaimer that extended to subsequent patents in the family. In reaching this conclusion, the court rejected an attempt by the patentee to resurrect the claim scope through a unilateral, self-serving statement made in later applications in the family.

...

Read More

IP Newsflash

May 13, 2025

The Federal Circuit recently affirmed a district court’s holding that patent term extension (PTE) for a reissued patent was properly based on the issue date of the original patent and not that of the reissued patent. The Federal Circuit concluded that, where both the original and reissued patents claimed a drug product under regulatory review, using the issue date of the original patent to calculate PTE comports with both the purpose of the Hatch-Waxman Act and the related statutory context.

...

Read More

IP Newsflash

May 12, 2025

The Patent Trial and Appeal Board recently declined to institute a petition for IPR that was filed on the same day that the petitioner filed another petition challenging the same claims of the same patent. The board was not persuaded by petitioner’s arguments that a second petition was needed due to alleged claim construction issues or the number, length or scope differences of the challenged claims.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.